ECP Combination Study

CompletedOBSERVATIONAL
Enrollment

319

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

June 15, 2022

Study Completion Date

June 15, 2022

Conditions
Steroid Refractory GVHD
Interventions
DRUG

Ruxolitinib

As per treating physician's decision - non interventional study

DEVICE

Extracorporeal photopheresis

As per treating physician's decision - non interventional study

DRUG

Ibrutinib

As per treating physician's decision - non interventional study

Trial Locations (38)

Unknown

Antwerp University, Antwerp

University of Liège, Liège

Rigshospitalet, Copenhagen

CHRU Angers, Angers

CHU de Limoges, Limoges

Institut de Cancerologie Lucien Neuwirth, Saint-Etienne

Bonn University, Bonn

University Hospital Essen, Essen

Universitaetsmedizin Mannheim, Mannheim

Robert_Bosch_Krankenhaus, Stuttgart

George Papanicolaou General Hospital, Thessaloniki

Rambam Medical Center, Haifa

H SS. Antonio e Biagio, Alessandria

ASST Papa Giovanni XXIII, Bergamo

Istituto Clinico Humanitas, Milan

Ospedale Civile, Pescara

Azienda Ospedaliero Universitaria Pisana, Pisa

Universita Cattolica S. Cuore, Roma

S. Bortolo Hospital, Vicenza

Medical University of Gdansk, Gdansk

Fundeni Clinical Institute, Bucharest

First State Pavlov Medical University of St. Petersburg, Saint Petersburg

ICO-Hospital Universitari Germans Trias i Pujol, Badalona

Hospital Clinic, Barcelona

ICO - Hospital Duran i Reynals, Barcelona

Hosp. Reina Sofia, Córdoba

Hospital Univ. Virgen de las Nieves, Granada

Hospital Regional de Málaga, Málaga

Hospital Universitario Virgen del Rocío, Seville

Sahlgrenska University Hospital, Gothenburg

Skanes University Hospital, Lund

Baskent University Hospital, Adana

Gazi University Faculty of Medicine, Ankara

University Hospital Birmingham NHS Trust, Birmingham

Bristol Royal Hospital for Children, Bristol

Kings College Hospital, London

Christie NHS Trust Hospital, Manchester

Churchill Hospital, Oxford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

European Society for Blood and Marrow Transplantation

NETWORK